Cannabis and the Endocannabinoid System: The Wonders of CBDs

Updated with PAiNT Research Palette – Green

Co-edited by Steven Smith, PAiNT Research   Hemp Is Now A Viable Agriculture Phenomenon Cannabis and the Endocannabinoid System; The Wonders of CBDs CBD Molecule The following is a reprint with updated references. Cannabinoids are the chemical compounds made by the cannabis plant that unlock its many healing secrets. There are over 100 known cannabinoids and these chemicals imitate the endocannabinoids naturally produced in the human body. The shiny little crystals you see on cannabis buds are called trichomes where cannabinoids are stored. Human bodies (and many animals) have endocannabinoid systems (ECS), meaning that cannabinoids are naturally made so they can bind to endocannabinoid receptors creating changes in our physiology. To understand the master gland and immune system of the human body it is crucial to have a basic understanding of the endogenous cannabinoid system, otherwise known as the endocannabinoid system (ECS). The endocannabinoid system is essential to human health because it maintains homeostasis in the body. Research into the endocannabinoid system has increased in recent years as scientists begin to reveal how complex and important this system is to our bodies. The legal cannabis movement started in San Francisco in the early 1990’s when it was discovered that cannabis treated many symptoms that AIDS patients suffered from, including pain. It was medical marijuana laws that changed the legal status of cannabis nationwide, opening the doors for research and an adult-use market and creating a path towards full legalization. Cannabis patients across the country have used the plant to treat a growing number of medical conditions. In Colorado alone, there are nine different qualifying conditions for a medical card: cancer, glaucoma, HIV or AIDS, cachexia (wasting syndrome), persistent muscle spasms, seizures, severe nausea, severe pain, and Post Traumatic Stress Disorder (PTSD).

  What Do CBD’s Do? The endocannabinoid system (ECS) is responsible for maintaining homeostasis in the body. Homeostasis is defined as: “any self-regulating process by which biological systems tend to maintain stability while adjusting to conditions that are optimal for survival.” If homeostasis is successful, life continues; if unsuccessful, disaster and ill health ensues. The endocannabinoid system is made up of three parts: cannabinoid receptors, endocannabinoids, and metabolic enzymes.   • Endocannabinoid receptors are found throughout the body on the surface of cells in the brain, organs, tissues, and glands. These receptors are embedded in cell membranes and produce varying reactions when stimulated by cannabinoids. • Cannabinoids come from two distinct places — the body, which produces naturally occurring endocannabinoids, and foods like the cannabis plant, which produces phytocannabinoids. • Metabolic enzymes act like a natural referee in that they destroy endocannabinoids once they are used up by the body. The two main metabolic enzymes are fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). This self-regulating system ensures the interaction of CBDs with the ECS only happens when needed and therefore keeps the workings of the endocannabinoid system relatively quiet to the conscious brain. Because homeostasis is so important to health, all vertebrates and invertebrates are known to have an endocannabinoid system.

  Cannabinoids can also be produced synthetically. Marinol (dronabinol) and Cesamet (nabilone) are synthetic versions of THC that have FDA approval to be marketed and sold as a prescription drug. Synthetic cannabinoids do unlock the endocannabinoid system to produce effects, but they often fail to incorporate the entourage effect which states that the sum of the different cannabinoids works better as a whole unit than any cannabinoid individually. With an understanding of the endocannabinoid system and its role in ensuring homeostasis in the body, it may be easier to see how this could be true. The Endocannabinoid System Despite its critical importance, the endocannabinoid system (ECS) was only discovered in the early 1990s when Lisa Matsuda, a researcher at the National Institute of Mental Health, and her colleagues discovered a DNA sequence that defines a THC-sensitive receptor in a rat’s brain. This discovery was quickly followed up with further evidence by Dr. Raphael Mechoulam, the famous chemist who discovered THC. With less than 30 years of research, the endocannabinoid system is one of the least studied systems in the body. Currently, restrictions on cannabis research limit what scientists can examine in terms of furthering the understanding of how cannabis and hemp interact with the endocannabinoid system. Two cannabinoid receptors have been discovered by researchers: CB1 and CB2.

CB1 is found in the central and peripheral nervous system. It’s also found in the brain and is the receptor that THC interacts with, giving the user a “high.” CB2 receptors are predominantly found in the immune system and the gastrointestinal system where they regulate inflammatory responses in the bowels. CB2 receptors are also found in the brain, although not as densely as CB1 receptors. These receptors, a large part of the endocannabinoid system, play roles in regulating cardiovascular activity, appetite, mood, memory, and pain in the body. CBD does not fit exactly into either CB1 or CB2 receptors. CBD stimulates both receptors and causes a reaction without binding directly, creating changes in cells that contain them. CBD also binds to a protein-receptor couple, TRPV-1, responsible for regulating body temperature, pain, and inflammation. CBD is also known for counteracting the effects of THC, activating serotonin receptors, and inhibiting a gene attributed to several cancers.   CBD has grown in popularity recently as research and anecdotal evidence increasingly demonstrates the impact it can have on the body. The body’s endocannabinoid system reacts to CB1 and CB2 based upon the organ or bodily system that is sensitive to one or both. The brain is especially sensitive to CB1, the lungs to CB1, the spleen to CB2, the vascular system CB1, the pancreas to CB1 & CB2, the liver to CB1 & CB2, reproductive organs to CB1, the colon to CB2, the muscles to CB1, the immune system to CB2, and the bones to CB2. The endocannabinoid system (ECS) is also involved in regulating a variety of physiological and cognitive processes including fertility, pregnancy (during pre- and postnatal development) appetite, pain-sensation, mood, and memory, and in mediating the pharmacological effects of cannabis. The ECS is also involved in mediating some of the physiological and cognitive effects of voluntary physical exercise in humans and other animals, such as contributing to exercise-induced euphoria as well as modulating locomotor activity and motivational salience for rewards. In humans, the plasma concentration of certain endocannabinoids (i.e., anandamide) have been found to rise during physical activity; since endocannabinoids can effectively penetrate the blood–brain barrier, it has been suggested that anandamide, along with other euphoriant neurochemicals, contributes to the development of exercise-induced euphoria in humans, a state colloquially referred to as a runner’s high. Cannabinoids Cannabinoids are broadly known for their anti-seizure, anti-inflammatory, anti-nausea, anti-fungal, and anti-cancer effects — and science has just scratched the surface. How much these effects are expressed is a result of the entourage effect is not fully known. The entourage effect states that the cannabinoids work better in tandem than they do alone. THC and CBD produce stronger healing properties together that are shown differently based on their concentrations and the presence of other cannabinoids. In addition, terpenes, the oils that give cannabis its fragrance, contribute to the therapeutic effects of the plant on the body when paired with cannabinoids. The powerful combination of these naturally occurring chemicals produces the medical effects that have given cannabis its reputation as a wondrous medical agent.

  In California, there are twelve qualifying conditions for a medical cannabis card, including one described as, “any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient’s safety or physical or mental health.” There are over 100 known cannabinoids and we’ve only briefly described a few. There is a lot more research to be done to understand the intricacies of each cannabinoid and how they interact with each other. Cannabinoids can bind to receptor sites in either the brain (CB-1) or the body (CB-2). Cannabinoids will produce different effects on the body depending on which type of receptor site they bind to. Cannabis strains are filled with multiple cannabinoids that when consumed, bind to these sites, creating a symphony of effects on the body and thus corresponding to the wide variety of healing properties. This is why one plant can treat many different conditions. Cannabinoids begin as cannabinoid acids that are activated when heated. This heat-based activation, also known as decarboxylation, removes the acid from the molecule, turning it into a bioavailable compound that the body can register. The decarboxylated molecule is often more powerful and produces a different effect on the body than the acidic version. This is why you see both “THCA” and “THC” when looking at the contents of a cannabis strain.  

🌿 Introduction: A Living System of Discovery The endocannabinoid system (ECS) remains one of the most fascinating regulatory networks in human biology. From mood and sleep to immune balance and pain modulation, the ECS is a master regulator. Cannabinoids like CBD interact with this system in ways that continue to inspire both scientific inquiry and public imagination. With the PAiNT Research Optics Palette – Green, we bring a sharper lens to this evolving field—highlighting not only the breakthroughs but also the blind spots that demand further exploration.

🔬 Current Research Strides

• Clinical Expansion: CBD has moved from anecdotal wellness use into formal clinical trials for epilepsy, anxiety, inflammation, and neurodegenerative conditions.
• Mechanistic Insights: Researchers are mapping receptor subtypes (CB1, CB2, and beyond), uncovering how cannabinoids influence neurotransmitter release, immune signaling, and vascular health.
• Formulation Innovation: Advances in delivery systems—nanoemulsions, transdermal patches, and targeted oral formulations—are improving bioavailability and consistency.
• Agricultural Progress: Hemp cultivation under the 2018 Farm Bill has expanded genetic diversity, enabling strains optimized for high-CBD, low-THC production.

⚖️ Current Limitations

• Regulatory Barriers: Federal scheduling and fragmented state laws continue to slow large-scale, multi-site clinical trials.
• Data Gaps: Long-term safety data, especially for chronic use and polypharmacy interactions, remain incomplete.
• Standardization Issues: Variability in plant genetics, extraction methods, and labeling practices undermines reproducibility and consumer trust.
• Equity in Access: Research and product development often overlook marginalized communities most affected by health disparities and cannabis criminalization.

🎨 The PAiNT Optics Palette – Green

This editorial lens emphasizes sustainability, wellness, and regenerative potential. “Green” is not only the color of the plant but also a metaphor for growth, balance, and ecological responsibility. Through this palette, PAiNT Research frames CBD and ECS science as part of a broader movement toward integrative health and environmental stewardship.

🚀 Preparing for PAiNT Your Wagon

This blog is the first in a living research series. The next installment, PAiNT Your Wagon, will expand the conversation—exploring how predictive AI, narrative storytelling, and community engagement can accelerate cannabinoid research and policy reform. Together, these pieces will form a living research blog, where each chapter builds on the last, offering readers not just information but a roadmap for advocacy, innovation, and wellness.

✅ Closing Note The ECS is not just a scientific curiosity—it is a bridge between biology, wellness, and culture. By applying the PAiNT Research Optics Palette – Green, we illuminate both the promise and the challenges of CBD research, preparing the ground for deeper inquiry and collective action.  

AllRightsReserved-InspirationalTechnologies2024

I hope this information was helpful and informative. If you have any more questions, please feel free to ask me. 😊 Inspirational Technologies – IT is Time

We, at Inspirational Technologies are at the forefront of Inspirational and Frontrunners on the frontier of current technology.

We are often faced with our own personal conflicts which directly influence our interactions with our peers and family. 

At Inspirational Technologies

Our mission is to shape public perception and policy through credible, engaging narratives that empower communities. With the PaiNT Network, we are extending that mission into the realm of predictive intelligence. By blending editorial rigor with AI foresight, we are creating a platform that doesn’t just inform—it inspires action.

As Steven Smith notes:

Looking Ahead The launch of PaiNT Research is only the beginning. In the coming months, Inspirational Technologies will:

• Roll out “Engage → Palette” cycles on our blog, showing how dialogue evolves into curated insights. • Publish “PaiNT Your Wagon” action briefs to guide policymakers and advocates. • Release “PaiNT You a Picture” visuals to make complex science accessible. • Amplify insights through “PaiNT the Town”, ensuring that predictive intelligence reaches the audiences who need it most.

A Call to Collaboration We believe that predictive intelligence is not a solitary pursuit—it is a collective canvas. Every voice adds a brushstroke. Every perspective adds depth. Together, we can paint a future where research is not just conducted but understood; not just published but lived. Join us as we launch PaiNT Research. Explore the categories. Share your insights. Because the future is not something we wait for—it’s something we paint together.

Brought to you by the PaiNT Network (2025) an inspiration from Inspirational Technologies

=====================================================================================================================================

We, at Inspirational Technologies are at the forefront of Inspirational and Front runners on the frontier of current technology. ___________________________________________________________________________________________________All Rights Reserved – Inspirational Technologies 2025 We hope this information has been helpful and informative. Don’t hesitate to reach out with any further questions. 😊